about
Bone Tissue EngineeringThe chorioallantoic membrane (CAM) assay for the study of human bone regeneration: a refinement animal model for tissue engineering.Xanthine oxidase mediates cytokine-induced, but not hormone-induced bone resorptionBiocompatibility and osteogenic potential of human fetal femur-derived cells on surface selective laser sintered scaffolds.Xanthine oxidase is a peroxynitrite synthase: newly identified roles for a very old enzyme.The effects of 1α, 25-dihydroxyvitamin D3 and transforming growth factor-β3 on bone development in an ex vivo organotypic culture system of embryonic chick femora.In Vivo Assessment of Bone Regeneration in Alginate/Bone ECM Hydrogels with Incorporated Skeletal Stem Cells and Single Growth Factors.Regionally-derived cell populations and skeletal stem cells from human foetal femora exhibit specific osteochondral and multi-lineage differentiation capacity in vitro and ex vivoHuman endothelial and foetal femur-derived stem cell co-cultures modulate osteogenesis and angiogenesis.Skeletal stem cells: phenotype, biology and environmental niches informing tissue regeneration.Skeletal stem cells and bone regeneration: translational strategies from bench to clinic.A new take on an old story: chick limb organ culture for skeletal niche development and regenerative medicine evaluation.Concise review: bridging the gap: bone regeneration using skeletal stem cell-based strategies - where are we now?Tissue engineered bone using select growth factors: A comprehensive review of animal studies and clinical translation studies in man.The application of human bone marrow stromal cells and poly(dl-lactic acid) as a biological bone graft extender in impaction bone grafting.Xanthine oxidase: four roles for the enzyme in rheumatoid pathology.The effect of mesenchymal populations and vascular endothelial growth factor delivered from biodegradable polymer scaffolds on bone formation.Expansion of human bone marrow stromal cells on poly-(DL-lactide-co-glycolide) (PDL LGA) hollow fibres designed for use in skeletal tissue engineering.A comparison of polymer and polymer-hydroxyapatite composite tissue engineered scaffolds for use in bone regeneration. An in vitro and in vivo study.* The Chorioallantoic Membrane Assay for Biomaterial Testing in Tissue Engineering: A Short-Term In Vivo Preclinical Model.Evaluation of skeletal tissue repair, part 1: assessment of novel growth-factor-releasing hydrogels in an ex vivo chick femur defect model.Evaluation of skeletal tissue repair, part 2: enhancement of skeletal tissue repair through dual-growth-factor-releasing hydrogels within an ex vivo chick femur defect model.Controlled differentiation of human bone marrow stromal cells using magnetic nanoparticle technology.Isolation, differentiation, and characterisation of skeletal stem cells from human bone marrow in vitro and in vivo.Clay gels for the delivery of regenerative microenvironments.3D human bone marrow stromal and endothelial cell spheres promote bone healing in an osteogenic nicheRemodelling of human bone on the chorioallantoic membrane of the chicken egg: De novo bone formation and resorptionHarnessing Human Decellularized Blood Vessel Matrices and Cellular Construct Implants to Promote Bone Healing in an Ex Vivo Organotypic Bone Defect ModelStrategies for cell manipulation and skeletal tissue engineering using high-throughput polymer blend formulation and microarray techniquesIGF-I increases bFGF-induced mitogenesis and upregulates FGFR-1 in rabbit vascular smooth muscle cellsEffect of faradic products on direct current-stimulated calvarial organ culture calcium levelsDetection and cellular localization of heparin-binding epidermal growth factor-like growth factor mRNA and protein in human atherosclerotic tissueA reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donorPulsed electromagnetic fields simultaneously induce osteogenesis and upregulate transcription of bone morphogenetic proteins 2 and 4 in rat osteoblasts in vitro
P50
Q26776037-CAFED9A4-3BF6-44A7-8CDE-BB16A8FA5FEBQ27314822-DA57C8F9-A0BE-4683-B959-10A02BF1893BQ28577579-E0B9E8E1-D042-4246-9601-985EFE505D52Q33429355-9EE98106-A9F5-453F-BF26-ABC0059BCAB8Q34790915-0741B279-A6B0-4E53-A708-2EA4533C827EQ35593203-39B30FAE-0524-40E8-9635-E9950487EA07Q35870778-27D8B31B-E56D-462A-9B47-8E73916537ADQ36383344-6194DB74-F97D-4278-B5EB-4E8AFE7D4FB7Q36476296-3C34F46A-6B1D-4842-9BB5-7F56F53E3C5BQ37131597-2F3DD963-DDA6-4A00-BB27-5520C16AB18CQ37834563-A9B9C8B7-F6E5-4B49-AF1E-76AF8DD1A3DDQ38136588-7702E8E4-560B-458E-BFCC-B90B64C58508Q38151642-1F0DDD4D-02DF-46E9-946E-ECB43D0AFE88Q38256886-8AC4F940-9646-431D-9232-74D567D906F4Q40095557-480B462D-3CE6-4BC8-8E6D-CAE4B422E909Q41655439-FFB1A35C-DFB8-48B7-8343-E89D98FA9663Q44947797-43A0AC47-902E-42A5-A786-DA016EE93AE6Q46059880-EA21BFEB-F4B5-4680-B6FD-5836FD0D6F29Q46832249-A7B59E39-229C-4293-A581-A762E582E8B8Q47709438-049A3BE3-6CD4-41B2-8B83-1A3EE7AA05F7Q50468459-38C131BF-0E3F-44D6-9D4D-3C9AFC5E08C3Q50469447-5064A376-83F7-4A61-B6CD-D10F09265C47Q50551980-35496A96-DB56-4968-92B8-3B2748EECCE2Q51839848-925FDD4A-2873-46D3-B218-D8E2CFE54657Q51864555-D99058B8-F6F9-4B5B-96C1-FE47AF9C8FEAQ58595257-66AD9988-13AB-4D7D-A1F0-196AFD0B2440Q61961160-C3FD68AF-9B91-41B0-9EFF-BC3EE6709E3CQ61961161-B26FC7F9-A5DC-4002-8083-9DCB7BB7FE0CQ61961198-BBBAE702-6658-4054-9C05-8F094C523953Q71897388-A39A08F3-8BEE-4616-812E-8C84C88DD5C3Q73138644-57A7D6EF-748A-4503-97E1-3944E4C8E367Q73504241-0BD7FEE3-2BEE-4EED-A4DD-0E6ED87A7521Q74723858-E93C5B87-2D71-43C7-BA91-181D41398DDCQ77350693-4708079C-0166-406B-8BF6-53607131EB34
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-7249-0414
@en
name
Janos M Kanczler
@ast
Janos M Kanczler
@en
Janos M Kanczler
@es
Janos M Kanczler
@nl
type
label
Janos M Kanczler
@ast
Janos M Kanczler
@en
Janos M Kanczler
@es
Janos M Kanczler
@nl
altLabel
Kanczler JM
@en
prefLabel
Janos M Kanczler
@ast
Janos M Kanczler
@en
Janos M Kanczler
@es
Janos M Kanczler
@nl
P106
P1153
15076555000
P31
P496
0000-0001-7249-0414